Literature DB >> 20131394

Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study.

Petra Schwingenschuh1, Diane Ruge, Mark J Edwards, Carmen Terranova, Petra Katschnig, Fatima Carrillo, Laura Silveira-Moriyama, Susanne A Schneider, Georg Kägi, Francisco J Palomar, Penelope Talelli, John Dickson, Andrew J Lees, Niall Quinn, Pablo Mir, John C Rothwell, Kailash P Bhatia.   

Abstract

Approximately 10% of patients diagnosed clinically with early Parkinson's disease (PD) have normal dopaminergic functional imaging (Scans Without Evidence of Dopaminergic Deficit [SWEDDs]). An important subgroup of SWEDDs are those with asymmetric rest tremor resembling parkinsonian tremor. Clinical and pathophysiological features which could help to distinguish SWEDDs from PD have not been explored. We therefore studied clinical details including non-motor symptoms in 25 tremulous SWEDDs patients in comparison to 25 tremor-dominant PD patients. Blinded video rating was used to compare examination findings. Electrophysiological tremor parameters and also response to a cortical plasticity protocol using paired associative stimulation (PAS) was studied in 9 patients with SWEDDs, 9 with tremor-dominant PD (with abnormal dopamine transporter single photon emission computed tomography findings), 8 with segmental dystonia, and 8 with essential tremor (ET). Despite clinical overlap, lack of true bradykinesia, presence of dystonia, and head tremor favored a diagnosis of SWEDDs, whereas re-emergent tremor, true fatiguing or decrement, good response to dopaminergic drugs, and presence of non-motor symptoms favored PD. A single tremor parameter could not differentiate between groups, but the combination of re-emergent tremor and highest tremor amplitude at rest was characteristic of PD tremor. SWEDDs and segmental dystonia patients exhibited an abnormal exaggerated response to the PAS protocol, in contrast to a subnormal response in PD and a normal response in ET. We conclude that despite clinical overlap, there are features that can help to distinguish between PD and SWEDDs which may be useful in clinical practice. The underlying pathophysiology of SWEDDs differs from PD but has similarities with primary dystonia. (c) 2010 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20131394      PMCID: PMC2996567          DOI: 10.1002/mds.23019

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  43 in total

1.  Induction of plasticity in the human motor cortex by paired associative stimulation.

Authors:  K Stefan; E Kunesch; L G Cohen; R Benecke; J Classen
Journal:  Brain       Date:  2000-03       Impact factor: 13.501

2.  Rating scales for dystonia: a multicenter assessment.

Authors:  Cynthia L Comella; Sue Leurgans; Joanne Wuu; Glenn T Stebbins; Teresa Chmura
Journal:  Mov Disord       Date:  2003-03       Impact factor: 10.338

Review 3.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

4.  Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Authors:  Alan L Whone; Ray L Watts; A Jon Stoessl; Margaret Davis; Sven Reske; Claude Nahmias; Anthony E Lang; Olivier Rascol; Maria J Ribeiro; Philippe Remy; Werner H Poewe; Robert A Hauser; David J Brooks
Journal:  Ann Neurol       Date:  2003-07       Impact factor: 10.422

Review 5.  Essential tremor. Epidemiology, diagnosis, and treatment.

Authors:  Kelly L Sullivan; Robert A Hauser; Theresa A Zesiewicz
Journal:  Neurologist       Date:  2004-09       Impact factor: 1.398

Review 6.  Classification and genetics of dystonia.

Authors:  Patricia M de Carvalho Aguiar; Laurie J Ozelius
Journal:  Lancet Neurol       Date:  2002-09       Impact factor: 44.182

7.  Abnormal associative plasticity of the human motor cortex in writer's cramp.

Authors:  Angelo Quartarone; Sergio Bagnato; Vincenzo Rizzo; Hartwig R Siebner; Vincenzo Dattola; Antonio Scalfari; Francesca Morgante; Fortunato Battaglia; Marcello Romano; Paolo Girlanda
Journal:  Brain       Date:  2003-09-23       Impact factor: 13.501

8.  Familial aggregation of Parkinson's disease: The Mayo Clinic family study.

Authors:  Walter A Rocca; Shannon K McDonnell; Kari J Strain; James H Bower; J Eric Ahlskog; Alexis Elbaz; Daniel J Schaid; Demetrius M Maraganore
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

9.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

10.  Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion.

Authors:  N P Quinn; J C Rothwell; P D Thompson; C D Marsden
Journal:  Adv Neurol       Date:  1988
View more
  68 in total

Review 1.  Neuroimaging in Parkinson's disease.

Authors:  A Jon Stoessl
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease.

Authors:  Alberto J Espay; Joe P Giuffrida; Robert Chen; Megan Payne; Filomena Mazzella; Emily Dunn; Jennifer E Vaughan; Andrew P Duker; Alok Sahay; Sang Jin Kim; Fredy J Revilla; Dustin A Heldman
Journal:  Mov Disord       Date:  2011-09-23       Impact factor: 10.338

3.  Computer-Aided Diagnosis of Parkinson's Disease Using Enhanced Probabilistic Neural Network.

Authors:  Thomas J Hirschauer; Hojjat Adeli; John A Buford
Journal:  J Med Syst       Date:  2015-09-29       Impact factor: 4.460

Review 4.  Rest tremor in dystonia: epidemiology, differential diagnosis, and pathophysiology.

Authors:  Navnika Gupta; Sanjay Pandey
Journal:  Neurol Sci       Date:  2020-04-23       Impact factor: 3.307

5.  Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease.

Authors:  Martin Niethammer; Chris C Tang; Peter A LeWitt; Ali R Rezai; Maureen A Leehey; Steven G Ojemann; Alice W Flaherty; Emad N Eskandar; Sandra K Kostyk; Atom Sarkar; Mustafa S Siddiqui; Stephen B Tatter; Jason M Schwalb; Kathleen L Poston; Jaimie M Henderson; Roger M Kurlan; Irene H Richard; Christine V Sapan; David Eidelberg; Matthew J During; Michael G Kaplitt; Andrew Feigin
Journal:  JCI Insight       Date:  2017-04-06

6.  Clinical routine use of dopamine transporter imaging in 516 consecutive patients.

Authors:  Claire Thiriez; Emmanuel Itti; Gilles Fénelon; Eva Evangelista; Michel Meignan; Pierre Cesaro; Philippe Remy
Journal:  J Neurol       Date:  2015-02-04       Impact factor: 4.849

7.  Effects of subthalamic nucleus stimulation on motor cortex plasticity in Parkinson disease.

Authors:  Sang Jin Kim; Kaviraja Udupa; Zhen Ni; Elena Moro; Carolyn Gunraj; Filomena Mazzella; Andres M Lozano; Mojgan Hodaie; Anthony E Lang; Robert Chen
Journal:  Neurology       Date:  2015-07-08       Impact factor: 9.910

Review 8.  Milestones in clinical neurophysiology.

Authors:  Mark Hallett; John Rothwell
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

9.  Screening for dopa-responsive dystonia in patients with Scans Without Evidence of Dopaminergic Deficiency (SWEDD).

Authors:  Anna De Rosa; Claudia Carducci; Carla Carducci; Silvio Peluso; Maria Lieto; Andrea Mazzella; Francesco Saccà; Vincenzo Brescia Morra; Sabina Pappatà; Vincenzo Leuzzi; Giuseppe De Michele
Journal:  J Neurol       Date:  2014-09-03       Impact factor: 4.849

Review 10.  Parkinsonian syndromes.

Authors:  David R Williams; Irene Litvan
Journal:  Continuum (Minneap Minn)       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.